Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling

Geng,Feng; Jiang,Zhanshi; Song,Xiaogang; Zhou,Haomin; Zhao,Hongwen

doi:10.3892/ijo.2017.4154

Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling

Authors:
- Feng Geng
- Zhanshi Jiang
- Xiaogang Song
- Haomin Zhou
- Hongwen Zhao
View Affiliations

Affiliations: Department of Pulmonary Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: October 12, 2017 https://doi.org/10.3892/ijo.2017.4154
Pages: 1898-1908

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mineral dust-induced gene (mdig) can inhibit the invasion and metastasis of A549 cells. The main purpose of this study was to explore the molecular mechanism underlying the inhibitory effect of mdig on cell invasion and metastasis. Mdig-knockdown and mdig-overexpressing A549 cells and an mdig-overexpressing human umbilical vein endothelial cell (HUVEC) line were constructed using lentiviral vectors, and western blot analysis was performed to verify the silencing and overexpression of the mdig protein. A Transwell invasion assay was used to detect the invasive abilities of each experimental group, and Transwell migration and scratch assays were used to detect cell migration ability. Western blotting was subsequently conducted to detect the major biochemical indices of the GSK-3β/β-catenin pathway and the protein expression levels and modifications of epithelial‑mesenchymal transition (EMT) transcription factors, as well as changes in the expression levels of EMT molecular markers and intercellular adhesion proteins. The results indicated that overexpression of mdig in A549 cells inhibited cell invasion and metastasis, while silencing of mdig increased the invasive and metastatic properties of cells. The molecular mechanism underlying the effects of mdig downregulation on A549 cell invasion and metastasis was found to involve the inhibition of GSK-3β phosphorylation, which in turn promoted the phosphorylation and destabilization of β-catenin. This was associated with downregulation of the downstream transcription factors slug, snail and ZEB1, thus leading to increased expression levels of epithelial cell markers and upregulation of the intercellular adhesion molecules E-cadherin, claudin‑1, ZO‑1, integrin β1 and integrin β4, which was accompanied by downregulation of the mesenchymal cell markers vimentin and N-cadherin. The HUVECs were used to validate the aforementioned molecular mechanisms and the same conclusions were obtained. The present results indicate that mdig can inhibit the phosphorylation of GSK-3β and promote the phosphorylation and destabilization of β-catenin, in order to suppress the expression of slug, snail, and ZEB1 and the occurrence of EMT, and thereby inhibit the invasion and metastasis of non-small cell lung cancer (NSCLC).

View Figures

View References

1	Zhang Y, Lu Y, Yuan BZ, Castranova V, Shi X, Stauffer JL, Demers LM and Chen F: The Human mineral dust-induced gene, mdig, is a cell growth regulating gene associated with lung cancer. Oncogene. 24:4873–4882. 2005. View Article : Google Scholar : PubMed/NCBI
2	Sun J, Yu M, Lu Y, Thakur C, Chen B, Qiu P, Zhao H and Chen F: Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation. Cancer Lett. 346:257–263. 2014. View Article : Google Scholar : PubMed/NCBI
3	Wu K, Li L, Thakur C, Lu Y, Zhang X, Yi Z and Chen F: Proteomic characterization of the World Trade Center dust-activated mdig and c-myc signaling circuit linked to multiple myeloma. Sci Rep. 6:363052016. View Article : Google Scholar : PubMed/NCBI
4	Ma D, Guo D, Li W and Zhao H: Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1). Tumour Biol. 36:6909–6917. 2015. View Article : Google Scholar : PubMed/NCBI
5	Tan XP, Dong WG, Zhang Q, Yang ZR, Lei XF and Ai MH: Potential effects of Mina53 on tumor growth in human pancreatic cancer. Cell Biochem Biophys. 69:619–625. 2014. View Article : Google Scholar : PubMed/NCBI
6	Yu M, Sun J, Thakur C, Chen B, Lu Y, Zhao H and Chen F: Paradoxical roles of mineral dust induced gene on cell proliferation and migration/invasion. PLoS One. 9:e879982014. View Article : Google Scholar : PubMed/NCBI
7	Tsuneoka M, Koda Y, Soejima M, Teye K and Kimura H: A novel myc target gene, mina53, that is involved in cell proliferation. J Biol Chem. 277:35450–35459. 2002. View Article : Google Scholar : PubMed/NCBI
8	Chen B, Yu M, Chang Q, Lu Y, Thakur C, Ma D, Yi Z and Chen F: Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin. Oncotarget. 4:1427–1437. 2013. View Article : Google Scholar : PubMed/NCBI
9	Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, et al: Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. J Cancer Res Clin Oncol. 136:465–473. 2010. View Article : Google Scholar
10	Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
11	Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
12	Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and metastasis in colorectal cancer: Epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs. 179:56–65. 2005. View Article : Google Scholar : PubMed/NCBI
13	Thiery JP, Acloque H, Huang RY and Nieto MA: Epithelial-mesenchymal transitions in development and disease. Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
14	Cuyàs E, Corominas-Faja B and Menendez JA: The nutritional phenome of EMT-induced cancer stem-like cells. Oncotarget. 5:3970–3982. 2014. View Article : Google Scholar : PubMed/NCBI
15	Godde NJ, Galea RC, Elsum IA and Humbert PO: Cell polarity in motion: Redefining mammary tissue organization through EMT and cell polarity transitions. J Mammary Gland Biol Neoplasia. 15:149–168. 2010. View Article : Google Scholar : PubMed/NCBI
16	Ren ZX, Yu HB, Li JS, Shen JL and Du WS: Suitable parameter choice on quantitative morphology of A549 cell in epithelial-mesenchymal transition. Biosci Rep. 35:352015.
17	Yost C, Torres M, Miller JR, Huang E, Kimelman D and Moon RT: The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10:1443–1454. 1996. View Article : Google Scholar : PubMed/NCBI
18	Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
19	Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
20	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
21	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
22	Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, et al: Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. Lung Cancer. 69:232–238. 2010. View Article : Google Scholar
23	Thakur C, Lu Y, Sun J, Yu M, Chen B and Chen F: Increased expression of mdig predicts poorer survival of the breast cancer patients. Gene. 535:218–224. 2014. View Article : Google Scholar :
24	Huo Q, Ge C, Tian H, Sun J, Cui M, Li H, Zhao F, Chen T, Xie H, Cui Y, et al: Dysfunction of IKZF1/MYC/MDIG axis contributes to liver cancer progression through regulating H3K9me3/p21 activity. Cell Death Dis. 8:e27662017. View Article : Google Scholar : PubMed/NCBI
25	Xing J, Wang K, Liu PW, Miao Q and Chen XY: Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma. Oncol Rep. 31:634–640. 2014. View Article : Google Scholar
26	Ogasawara S, Komuta M, Nakashima O, Akiba J, Tsuneoka M and Yano H: Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma. Hepatology Res. 40:330–336. 2010. View Article : Google Scholar
27	Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, Kuwano M, Tajiri T, Taguchi T, Tsuneyoshi M and Kojiro M: Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J Pediatr Surg. 42:1831–1840. 2007. View Article : Google Scholar : PubMed/NCBI
28	Ishizaki H, Yano H, Tsuneoka M, Ogasawara S, Akiba J, Nishida N, Kojiro S, Fukahori S, Moriya F, Matsuoka K, et al: Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int. 57:672–680. 2007. View Article : Google Scholar : PubMed/NCBI
29	Teye K, Arima N, Nakamura Y, Sakamoto K, Sueoka E, Kimura H and Tsuneoka M: Expression of Myc target gene mina53 in subtypes of human lymphoma. Oncol Rep. 18:841–848. 2007.PubMed/NCBI
30	Tsuneoka M, Fujita H, Arima N, Teye K, Okamura T, Inutsuka H, Koda K, Shirouzu K and Kimura H: Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. Clin Cancer Res. 10:7347–7356. 2004. View Article : Google Scholar : PubMed/NCBI
31	Kuratomi K, Yano H, Tsuneoka M, Sakamoto K, Kusukawa J and Kojiro M: Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma. Kurume Med J. 53:71–78. 2006. View Article : Google Scholar
32	Thakur C and Chen F: Current understanding of mdig/MINA in human cancers. Genes Cancer. 6:288–302. 2015.PubMed/NCBI